From left: GAYLE S. JAMESON, M.S.N, ACNP-BC, AOCN, and ERIN PIERCE, M.S.N., APRN, FNP-C; PHOTOS BY AZULA RAUN
Gayle S. Jameson, M.S.N, ACNP-BC, AOCN, an oncology nurse practitioner at HonorHealth Analysis Institute (HRI), is a trailblazer whose extraordinary experience and compassion have made a profound affect on oncology care and analysis.
With greater than 40 years of expertise, together with certification as a sophisticated oncology nurse, Gayle exemplifies professionalism and huge data in each side of her work, leaving an indelible mark on her sufferers, colleagues and the way forward for oncology.
At HRI, Gayle has championed the function of nurse practitioners as principal investigators (PIs) for section 1 scientific trials, historically a physician-led function. In her function as affiliate scientific investigator, she has been the PI on 14 section 1, 2, and investigator-initiated research. As well as, she has been a subinvestigator on tons of of phases 1 and a couple of antitumor scientific trials. She incorporates translational science into scientific trial designs by working with bench science colleagues on the Translational Genomics Analysis Institute, Princeton College, Mayo Clinic and Salk Institute for Organic Research. Gayle additionally was the positioning principal investigator on a global examine that led to the approval of Onivyde (nanoliposomal irinotecan) plus fluorouracil and leucovorin for sufferers with metastatic pancreatic most cancers.
In 2020, she revealed outcomes of a examine in JAMA Oncology that demonstrated important enchancment within the total survival of sufferers with superior pancreatic most cancers. Gayle’s experience has been showcased in additional than 30 revealed articles, together with ebook chapters, and greater than 35 abstracts. As a global speaker, her affect extends globally, additional cementing her management in oncology analysis and care.
Gayle’s skilled achievements are exceptional, however her deep compassion and empathy for sufferers are what actually set her aside. A poignant instance of her compassionate care is mirrored within the story of a affected person with newly recognized stage 4 pancreatic most cancers. This affected person, who was elevating his sister’s two youngsters, was understandably overwhelmed by his prognosis and unsure about his future. Gayle spent hours with him, rigorously explaining his prognosis, providing emotional help and answering his questions. She went above and past by connecting him with different sufferers with pancreatic most cancers who shared their experiences, giving him a way of group and, extra importantly, hope. By these conversations and her steerage, Gayle helped him to appreciate that he wasn’t simply one other statistic. She helped him discover hope and a plan.
This is only one small instance of the methods she goes above and past in all that she does, actually placing the affected person first. That is additionally a fantastic instance of how Gayle cares for her sufferers comprehensively, not simply specializing in the most cancers prognosis, but additionally making an allowance for different elements which might be usually a burden for sufferers. This emotional element, alongside together with her professional data, illustrates the profound affect she has on her sufferers and their households. Her capacity to supply not simply data but additionally hope is what makes her a rare caregiver. She continues to encourage these round her, and her progressive spirit in oncology analysis paves the best way for the way forward for most cancers care.
For extra information on most cancers updates, analysis and training, don’t neglect to subscribe to CURE®’s newsletters right here.
